- Isoquinoline
Chembox new
Name = Isoquinoline
ImageFile = Isoquinoline_chemical_structure.png
ImageSize = 450px
ImageName = Chemical structure of Isoquinoline
IUPACName = Isoquinoline
OtherNames = benzo [c] pyridine, 2-benzanine
Section1 = Chembox Identifiers
CASNo = 119-65-3
EINECS = 204-341-8
SMILES = C1(C=NC=C2)=C2C=CC=C1
Section2 = Chembox Properties
Formula = C9H7N
MolarMass = 129.16 g/mol
Appearance = yellowish oily liquid, hygroscopic
platelets when solid
Density = 1.099 g/cm³
MeltingPt = 26 - 28 °C
BoilingPt = 242 °CIsoquinoline, also known as benzo [c] pyridine or 2-benzanine, is a
heterocyclic aromatic organic compound . It is astructural isomer ofquinoline . Isoquinoline and quinoline arebenzopyridine s, which are composed of abenzene ring fused to apyridine ring. In a broader sense, the term isoquinoline is used to make reference to isoquinoline derivatives. Isoquinoline is the structural backbone in naturally occurringalkaloids includingpapaverine andmorphine . The isoquinoline ring in these natural compound derives from the aromaticamino acid tyrosine .Properties
Isoquinoline is a colorless
hygroscopic liquid at room temperature with a penetrating, unpleasant odor. Impure samples can appear brownish, as is typical for nitrogen heterocycles. It crystallizes platelets that have a lowsolubility inwater but dissolve well inethanol ,acetone ,diethyl ether ,carbon disulfide , and other commonorganic solvent s. It is also soluble in diluteacid s as the protonated derivative.Being an analog of
pyridine , isoquinoline is a weak base, with a pKb of 8.6. It protonates to formsalts upon treatment withstrong acid s, such as HCl. It formsadduct s withLewis acid s, such as BF3.Production
Isoquinolone was first isolated from
coal tar in 1885 by Hoogewerf and van Dorp. They isolated it by fractional crystallization of the acid sulfate. Weissgerber developed a more rapid route in 1914 by selective extraction of coal tar, exploiting the fact that isoquinoline is more basic than quinoline. Isoquinoline can then be isolated from the mixture by fractional crystallization of the acid sulfate.Although isoquinoline derivatives can be synthesized by several methods, relatively few direct methods deliver the unsubstituted isoquinoline. The Pomeranz-Fritsch reaction provides an efficient method for the preparation of isoquinoline:
* The Pomeranz-Fritsch reaction uses abenzaldehyde and aminoacetoaldehyde diethyl acetal, which in anacid medium react to form isoquinoline. Alternatively,benzylamine and aglyoxal acetal can be used, to produce the same result.The following methods are useful for the preparation of various isoquinoline derivatives:
* In the
Bischler-Napieralski reaction an β-phenylethylamine is acylated and cyclodehydrated by a Lewis acid, such as phosphoryl chloride or phosphorus pentoxide. The resulting 1-substituted-3,4-dihydroisoquinoline can then be dehydrogenated using palladium. The following Bischler-Napieralski reaction produces papaverine.:
* The Pictet-Gams and Pictet-Spengler syntheses are both variations on the Bischler-Napieralski reaction. The differences are as follows:
* ThePictet-Gams reaction avoids the finaldehydrogenation step of the Bischler-Napieralski reaction by constructing a β-phenylethylamine with a hydroxy group in theside chain . This reaction results in a 1-alkyl-isoquinoline.
* ThePictet-Spengler reaction combines a β-phenylethylamine and analdehyde in anacid medium, which cyclizes the imine in a reaction of the Mannich type. This produces thetetrahydroisoquinoline instead of thedihydroisoquinoline .
* Intramolecular aza Wittig reactions also afford isoquinolines.Applications of derivatives
Isoquinolines find many applications, including (but not limited to):
*anesthetics;dimethisoquin is one example (shown below).
*antihypertension agents, such asquinapril ,quinapirilat , and "debrisoquine" (all derived from 1,2,3,4-tetrahydroisoquinoline).
*antifungal agents, such as 2,2'Hexadecamethylenediisoquinolinium dichloride, which is also used as a topical antiseptic. This derivative, shown below, is prepared by N-alkylation of isoquinoline with the appropriate dihalide.
*disinfectants, like N-laurylisoquinolinium bromide (shown below), which is prepared by simple N-alkylation of isoquinoline.
*vasodilators, a well-known example,papaverine , shown below.Bisbenzylisoquinolinium compounds are compounds similar in structure to
tubocurarine . They have two isoquinolinium structures, linked by acarbon chain, containing twoester linkages.Isoquinolines and the human body
Parkinson's disease , a slowly progressing movement disorder, is thought to be caused by certainneurotoxins . A neurotoxin called MPTP (1 [N] -methyl-4-phenyl-1,2,3,6-tetrahydropyridine ), the precursor to MPP+, was found and linked to Parkinson's disease in the 1980's. The active neurotoxins destroydopaminergic neuron s, leading to parkinsonism and Parkinson's disease. Severaltetrahydroisoquinoline derivatives have been found to have the same neurochemical properties as MPTP. These derivatives may act as neurotoxin precursors to active neurotoxins.Other uses
Isoquinolines are used in the manufacture of
dyes ,paints ,insecticides andantifungal s. It is also used as asolvent for the extraction ofresins anterpenes , and as acorrosion inhibitor.ee also
*
Quinoline , an analog with the nitrogen atom in position 1.
*Pyridine , an analog without the fusedbenzene ring.
*Naphthalene , an analog without the nitrogen atom.
*Simple aromatic ring sReferences
Cited referencesGeneral references
# Gilchrist, T.L. (1997). "Heterocyclic Chemistry" (3rd ed.). Essex, UK: Addison Wesley Longman.
# Harris, J.; Pope, W.J. "iso"Quinoline and the "iso"Quinoline-Reds" Journal of the Chemical Society (1922) volume 121, pp. 1029-1033.
# Katritsky, A.R.; Pozharskii, A.F. (2000). "Handbook of Heterocyclic Chemistry" (2nd ed.). Oxford, UK: Elsevier.
# Katritsky, A.R.; Rees, C.W.; Scriven, E.F. (Eds.). (1996). "Comprehensive Heterocyclic Chemistry II: A Review of the Literature 1982-1995" (Vol. 5). Tarrytown, NY: Elsevier.
# Nagatsu, T. "Isoquinoline neurotoxins in the brain and Parkinson's disease" Neuroscience Research (1997) volume 29, pp. 99-111.
# O'Neil, Maryadele J. (Ed.). (2001). "The Merck Index" (13th ed.). Whitehouse Station, NJ: Merck.External links
Wikimedia Foundation. 2010.